// App-Quantinova.ai

134 : Utilisation of sodium glucose transport protein 2 sglt2 inhibitor in patients with cardiac resynchronisation therapy crt device a uk district general hospital perspective

Researchers

Presenter

  • Ronald Manorekang

Principal Investigators

  • Nathan Price

  • Iyad Ahmed

  • Chris Hayes

Medical Centers

  • The York and Scarborough Teaching Hospitals NHS Foundation Trust, Wigginton Road, York, YOR YO318HE, United Kingdom

  • York and Scarborough teaching hospitals NHS foundations trust

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • BI-10773

  • Dapagliflozin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved